Comprehensive Clinical Literature Monitoring Services
Ephicacy delivers structured, continuous review of global biomedical literature. Within an FSP model or through flexible project-based support, our teams adapt to your products, internal workflows, and reporting needs.
Our services include:
- Weekly monitoring of global, multilingual biomedical literature
- Coverage of scientific journals, case reports, conference abstracts, clinical trials, reviews, and grey literature
- Tracking of company products, drug relationships, and relevant drug classes
- Identification of safety-relevant information, including ADRs and emerging risk signals
- Analysis of competitor studies, providing context for how your product compares in the market
- Structured outputs designed to integrate seamlessly with your internal workflows
Flexible Delivery Models
Our delivery models adapt to your needs. Whether FSP, project-based, or consulting, we deliver high-quality analytics quickly, consistently, and within budget. We also offer hybrid models to accommodate multiple projects with differing needs.
Our weekly screening capacity exceeds 1,000+ global publications, and we have a proven track record that includes:
-
37,900+ articles screened
-
6,270+ articles reported on
-
5,300+ articles indexed
Clinically Relevant Screening With Strategic Automation
Effective drug safety monitoring requires more than basic checks. Ephicacy screens for clinically relevant information that pharmacovigilance teams use to evaluate product safety and potential risk, supported by experienced reviewers who assess publications in context and apply consistent decision-making across products and therapeutic areas. Additionally, use of AI tools as a complement to human expertise enables faster decision-making and more efficient screening.
Our teams review:
- Adverse drug reactions (ADRs)
- Off-label use and real-world utilization patterns
- Pregnancy exposure
- Misuse events
- Unexpected effects
- Other publications that may inform risk management, FDA compliance, safety communications, and ongoing pharmacovigilance activities
Custom Indexing That Builds Long-Term Value
Ephicacy applies a custom taxonomy and thesaurus, with the ability to adapt the system to your specific needs. Through this custom approach, we support consistent classification across literature types and create a structured, searchable product literature resource your teams can use over time. This results in faster retrieval of relevant evidence, clearer traceability, and a more usable internal literature base that is laser-focused on adverse events and safety.
A Quality System Designed for Consistency
Clinical literature monitoring depends on a standardized approach and knowledgeable teams. Ephicacy supports reliable delivery through training, documentation practices, and quality oversight designed to keep screening and indexing consistent week after week.
Key elements include:
- Multi-month training and qualification of clinical reviewers, with a >90% pass threshold, then a 4-week probationary period with 80%, 60%, 40%, and 20% spot checks, respectively
- Literature screening guidelines with detailed procedures tailored to each monitored drug or product
- Document management support, including deduplication and updates from early online or unpublished publications to final versions
- Thoughtful use of AI where it adds value, such as prioritizing the most relevant articles and streamlining indexing and quality control
Leverage Our Clinical Literature Monitoring Expertise
Ephicacy’s clinical literature review services support pharmacovigilance teams with dependable monitoring, clinically informed screening, and structured indexing that fits existing workflows. With broad biometrics expertise and high team retention, we help sponsors maintain continuity as products, evidence, and requirements evolve.
